ArticleCancers2020

Betulinic Acid-Mediated Tuning of PERK/CHOP Signaling by Sp1 Inhibition as a Novel Therapeutic Strategy for Glioblastoma.

Wei-Lun Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.